Two-tier approach to the newborn screening of methylenetetrahydrofolate reductase deficiency and other remethylation disorders with tandem mass spectrometry

Silvia Tortorelli, Coleman T. Turgeon, James S. Lim, Steve Baumgart, Debra Lynn Day-Salvatore, Jose Abdenur, Jonathan A. Bernstein, Fred Lorey, Uta Lichter-Konecki, Devin Oglesbee, Kimiyo Raymond, Dietrich Matern, Lisa Schimmenti, Piero Rinaldo, Dimitar K. Gavrilov

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

Objective: To validate a 2-tier approach for newborn screening (NBS) of remethylation defects. Study design: The original NBS dried blood spots of 5 patients with a proven diagnosis of a remethylation disorder and 1 patient with biochemical evidence of such disorder were analyzed retrospectively to determine disease ranges for methionine (Met; 4.7-8.1 μmol/L; 1 percentile of healthy population, 11.1 μmol/L), the methionine/phenylalanine ratio (Met/Phe; 0.09-0.16; 1 percentile of healthy population, 0.22), and total homocysteine (tHcy; 42-157 μmol/L; 99 percentile of normal population, 14.7 μmol/L). These preliminary disease ranges showed a sufficient degree of segregation from healthy population data, allowing the selection of cutoff values. A simple algorithm was then developed to reflex cases to a second-tier testing for tHcy, which has been applied prospectively for 14 months. Results: A total of 86 333 NBS samples were tested between January 2007 and March 2008, and 233 of them (0.27%) met the criteria for second-tier testing of tHcy. All cases revealed concentrations of tHcy <15 μmol/L and were considered unaffected. No false-negative results have been reported with a state-wide system based on 2 combined metabolic clinics and laboratories that cover the entire Minnesota population and border areas of neighboring states. Conclusions: Pending more conclusive evidence from the prospective identification of additional true-positive cases, NBS for remethylation disorders appears to be feasible with existing methodologies, with only a marginal increase of the laboratory workload.

Original languageEnglish (US)
Pages (from-to)271-275
Number of pages5
JournalJournal of Pediatrics
Volume157
Issue number2
DOIs
StatePublished - 2010

Fingerprint

Tandem Mass Spectrometry
Newborn Infant
Population
Methionine
Homocysteine
Workload
Phenylalanine
Reflex
Methylenetetrahydrofolate reductase deficiency

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Medicine(all)

Cite this

Two-tier approach to the newborn screening of methylenetetrahydrofolate reductase deficiency and other remethylation disorders with tandem mass spectrometry. / Tortorelli, Silvia; Turgeon, Coleman T.; Lim, James S.; Baumgart, Steve; Day-Salvatore, Debra Lynn; Abdenur, Jose; Bernstein, Jonathan A.; Lorey, Fred; Lichter-Konecki, Uta; Oglesbee, Devin; Raymond, Kimiyo; Matern, Dietrich; Schimmenti, Lisa; Rinaldo, Piero; Gavrilov, Dimitar K.

In: Journal of Pediatrics, Vol. 157, No. 2, 2010, p. 271-275.

Research output: Contribution to journalArticle

Tortorelli, S, Turgeon, CT, Lim, JS, Baumgart, S, Day-Salvatore, DL, Abdenur, J, Bernstein, JA, Lorey, F, Lichter-Konecki, U, Oglesbee, D, Raymond, K, Matern, D, Schimmenti, L, Rinaldo, P & Gavrilov, DK 2010, 'Two-tier approach to the newborn screening of methylenetetrahydrofolate reductase deficiency and other remethylation disorders with tandem mass spectrometry', Journal of Pediatrics, vol. 157, no. 2, pp. 271-275. https://doi.org/10.1016/j.jpeds.2010.02.027
Tortorelli, Silvia ; Turgeon, Coleman T. ; Lim, James S. ; Baumgart, Steve ; Day-Salvatore, Debra Lynn ; Abdenur, Jose ; Bernstein, Jonathan A. ; Lorey, Fred ; Lichter-Konecki, Uta ; Oglesbee, Devin ; Raymond, Kimiyo ; Matern, Dietrich ; Schimmenti, Lisa ; Rinaldo, Piero ; Gavrilov, Dimitar K. / Two-tier approach to the newborn screening of methylenetetrahydrofolate reductase deficiency and other remethylation disorders with tandem mass spectrometry. In: Journal of Pediatrics. 2010 ; Vol. 157, No. 2. pp. 271-275.
@article{cb70b717a8be4a64ad79151a902cfac3,
title = "Two-tier approach to the newborn screening of methylenetetrahydrofolate reductase deficiency and other remethylation disorders with tandem mass spectrometry",
abstract = "Objective: To validate a 2-tier approach for newborn screening (NBS) of remethylation defects. Study design: The original NBS dried blood spots of 5 patients with a proven diagnosis of a remethylation disorder and 1 patient with biochemical evidence of such disorder were analyzed retrospectively to determine disease ranges for methionine (Met; 4.7-8.1 μmol/L; 1 percentile of healthy population, 11.1 μmol/L), the methionine/phenylalanine ratio (Met/Phe; 0.09-0.16; 1 percentile of healthy population, 0.22), and total homocysteine (tHcy; 42-157 μmol/L; 99 percentile of normal population, 14.7 μmol/L). These preliminary disease ranges showed a sufficient degree of segregation from healthy population data, allowing the selection of cutoff values. A simple algorithm was then developed to reflex cases to a second-tier testing for tHcy, which has been applied prospectively for 14 months. Results: A total of 86 333 NBS samples were tested between January 2007 and March 2008, and 233 of them (0.27{\%}) met the criteria for second-tier testing of tHcy. All cases revealed concentrations of tHcy <15 μmol/L and were considered unaffected. No false-negative results have been reported with a state-wide system based on 2 combined metabolic clinics and laboratories that cover the entire Minnesota population and border areas of neighboring states. Conclusions: Pending more conclusive evidence from the prospective identification of additional true-positive cases, NBS for remethylation disorders appears to be feasible with existing methodologies, with only a marginal increase of the laboratory workload.",
author = "Silvia Tortorelli and Turgeon, {Coleman T.} and Lim, {James S.} and Steve Baumgart and Day-Salvatore, {Debra Lynn} and Jose Abdenur and Bernstein, {Jonathan A.} and Fred Lorey and Uta Lichter-Konecki and Devin Oglesbee and Kimiyo Raymond and Dietrich Matern and Lisa Schimmenti and Piero Rinaldo and Gavrilov, {Dimitar K.}",
year = "2010",
doi = "10.1016/j.jpeds.2010.02.027",
language = "English (US)",
volume = "157",
pages = "271--275",
journal = "Journal of Pediatrics",
issn = "0022-3476",
publisher = "Mosby Inc.",
number = "2",

}

TY - JOUR

T1 - Two-tier approach to the newborn screening of methylenetetrahydrofolate reductase deficiency and other remethylation disorders with tandem mass spectrometry

AU - Tortorelli, Silvia

AU - Turgeon, Coleman T.

AU - Lim, James S.

AU - Baumgart, Steve

AU - Day-Salvatore, Debra Lynn

AU - Abdenur, Jose

AU - Bernstein, Jonathan A.

AU - Lorey, Fred

AU - Lichter-Konecki, Uta

AU - Oglesbee, Devin

AU - Raymond, Kimiyo

AU - Matern, Dietrich

AU - Schimmenti, Lisa

AU - Rinaldo, Piero

AU - Gavrilov, Dimitar K.

PY - 2010

Y1 - 2010

N2 - Objective: To validate a 2-tier approach for newborn screening (NBS) of remethylation defects. Study design: The original NBS dried blood spots of 5 patients with a proven diagnosis of a remethylation disorder and 1 patient with biochemical evidence of such disorder were analyzed retrospectively to determine disease ranges for methionine (Met; 4.7-8.1 μmol/L; 1 percentile of healthy population, 11.1 μmol/L), the methionine/phenylalanine ratio (Met/Phe; 0.09-0.16; 1 percentile of healthy population, 0.22), and total homocysteine (tHcy; 42-157 μmol/L; 99 percentile of normal population, 14.7 μmol/L). These preliminary disease ranges showed a sufficient degree of segregation from healthy population data, allowing the selection of cutoff values. A simple algorithm was then developed to reflex cases to a second-tier testing for tHcy, which has been applied prospectively for 14 months. Results: A total of 86 333 NBS samples were tested between January 2007 and March 2008, and 233 of them (0.27%) met the criteria for second-tier testing of tHcy. All cases revealed concentrations of tHcy <15 μmol/L and were considered unaffected. No false-negative results have been reported with a state-wide system based on 2 combined metabolic clinics and laboratories that cover the entire Minnesota population and border areas of neighboring states. Conclusions: Pending more conclusive evidence from the prospective identification of additional true-positive cases, NBS for remethylation disorders appears to be feasible with existing methodologies, with only a marginal increase of the laboratory workload.

AB - Objective: To validate a 2-tier approach for newborn screening (NBS) of remethylation defects. Study design: The original NBS dried blood spots of 5 patients with a proven diagnosis of a remethylation disorder and 1 patient with biochemical evidence of such disorder were analyzed retrospectively to determine disease ranges for methionine (Met; 4.7-8.1 μmol/L; 1 percentile of healthy population, 11.1 μmol/L), the methionine/phenylalanine ratio (Met/Phe; 0.09-0.16; 1 percentile of healthy population, 0.22), and total homocysteine (tHcy; 42-157 μmol/L; 99 percentile of normal population, 14.7 μmol/L). These preliminary disease ranges showed a sufficient degree of segregation from healthy population data, allowing the selection of cutoff values. A simple algorithm was then developed to reflex cases to a second-tier testing for tHcy, which has been applied prospectively for 14 months. Results: A total of 86 333 NBS samples were tested between January 2007 and March 2008, and 233 of them (0.27%) met the criteria for second-tier testing of tHcy. All cases revealed concentrations of tHcy <15 μmol/L and were considered unaffected. No false-negative results have been reported with a state-wide system based on 2 combined metabolic clinics and laboratories that cover the entire Minnesota population and border areas of neighboring states. Conclusions: Pending more conclusive evidence from the prospective identification of additional true-positive cases, NBS for remethylation disorders appears to be feasible with existing methodologies, with only a marginal increase of the laboratory workload.

UR - http://www.scopus.com/inward/record.url?scp=77955288342&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77955288342&partnerID=8YFLogxK

U2 - 10.1016/j.jpeds.2010.02.027

DO - 10.1016/j.jpeds.2010.02.027

M3 - Article

C2 - 20394947

AN - SCOPUS:77955288342

VL - 157

SP - 271

EP - 275

JO - Journal of Pediatrics

JF - Journal of Pediatrics

SN - 0022-3476

IS - 2

ER -